Skip to main content
CiDA 2024 Main banner
Back

Shuvo Roy, PhD

Professor - Bioengineering & Therapeutic Sciences
UC San Francisco
UC San Francisco
San Franscisco, CA, United States

Shuvo Roy, PhD is a Professor in the Department of Bioengineering & Therapeutic Sciences at UC San Francisco (UCSF). He is the director of the Biodesign Laboratory and is the Faculty Director of the Master of Translational Medicine (MTM) program, which offers a healthcare technology innovation degree jointly with the UC Berkeley. His research focuses on the development of next-generation medical devices utlizing semiconductor microfabrication and nanotechnology approaches. He is the Technical Director of The Kidney Project, a national research project to create a small, surgically implanted, and free-standing bioartificial kidney to treat end-stage renal disease (ESRD). Other projects include the development of bioartificial pancreas devices, compact membrane oxygenators, wireless physiological monitoring systems, and point-of-care diagnostics. In addition, Dr. Roy is a founding member of the UCSF-Stanford Pediatric Device Consortium, which has a mission to accelerate the development of innovative devices for children’s health. He is co-leading UCSF’s Surgical Innovations program, an interdepartmental initiative with the Department of Surgery, to accelerate the translation of medical technologies. Before joining UCSF in 2008, Dr. Roy co-directed the BioMEMS Laboratory in the Department of Biomedical Engineering at the Cleveland Clinic. He has a PhD in electrical engineering and computer science from Case Western Reserve University in Cleveland, Ohio. He is the author of more than 125 publications and co-author of five book chapters, and holds multiple patents for device developments. He has developed and currently teaches a course focused on medical device development and commercialization issues. He is the recipient of numerous awards, including the MIT TR100, a NASA Group Achievement Award, the Rising Star Award by BayBio Pantheon, and mutliple prizes from KidneyX for his innovations to address the treatment of ESRD patients.

Disclosure information not submitted.

Presentation(s):